The National Gaucher Foundation looks back on the accomplishments of 2018, made possible by the support and participation of the Gaucher disease community.
At a recent symposium on Gaucher disease, nationally and internationally renowned Gaucher disease experts answered a variety of questions about the condition. Topics touched on everything from advances in gene therapy to the role of diet in Gaucher disease treatment to whether people with Gaucher disease have certain biological advantages. Read the Gaucher disease Q&A… Read More »
It’s no secret that living with Gaucher disease can be pricy. Enzyme replacement therapy (ERT), the mainstay of Gaucher disease management, runs between $139,000 to more than $300,000 each year(1). Patients often encounter unexpected expenses, including fees for emergency services and travel costs, during the course of their treatment. Many people living with Gaucher disease… Read More »
According to current estimates, as many as one in three Ashkenazi Jews, those with Eastern European descent, are carriers for certain genetic diseases, including Gaucher disease. Researchers think Ashkenazi genetic diseases arise because of the common ancestry many Jews share. While people from any ethnic group can develop genetic diseases, Ashkenazi Jews are at higher… Read More »
San Diego Patient Meeting
At the age of four, Brian Berman, National Gaucher Foundation’s CEO, was diagnosed with type 1 Gaucher disease after suffering severe symptoms. The first person in the world to successfully receive enzyme replacement therapy for Gaucher disease, Mr. Berman’s personal journey from sick child to dynamic professional and married father of five has prepared him… Read More »